Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Finafloxacin in otitis media with tympanostomy tubes
NCT02436304Phase 3Completed
- Sponsor
- Alcon Inc.
- Start
- Jun 2015
- Primary completion
- Aug 2016
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of finafloxacin in acute otitis media (AOM), Otitis media with effusion (OME), sponsored by Alcon Inc.. Started Jun 2015; status: completed.
02
Drugs
finafloxacin
03
Conditions
acute otitis media (AOM)Otitis media with effusion (OME)
Beyond the preview
Go deeper on NCT02436304.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02436304.